Snoring and daytime exhaustion can signal obstructive sleep apnea. Here's what the tirzepatide trial shows, what it doesn't, and what to track before your next visit.

If you take Mounjaro or are thinking about starting it, you may have wondered whether Mounjaro sleep apnea concerns apply to you. Snoring and daytime tiredness are easy to shrug off. But they can also come from obstructive sleep apnea, a condition where the upper airway repeatedly collapses during sleep. Each collapse reduces airflow, and the brain often triggers a brief awakening to reopen the airway. Most people never remember those moments.

A bed partner usually notices first. They might hear loud snoring, then silence, then a gasp or choking sound. Some describe watching someone stop breathing for several seconds before breathing resumes. If that sounds familiar, it deserves attention, even if you feel fine during the day.

Excess weight is a well-known risk factor, especially fat around the neck, because it can narrow the airway. Sleep apnea also differs from insomnia. Insomnia means trouble falling or staying asleep. Obstructive sleep apnea is a physical blockage, while central sleep apnea happens when the brain doesn't send the normal signal to breathe. Both can leave you drained, but they call for different evaluations.

What the trial data shows and what it doesn't

The main study behind this conversation is SURMOUNT-OSA, published in the New England Journal of Medicine in 2024. It tested tirzepatide in adults with obesity and moderate-to-severe obstructive sleep apnea. The primary measure was the apnea-hypopnea index, or AHI, which counts how many times per hour a person stops breathing or has a significant drop in airflow. In plain language, a lower AHI means fewer breathing interruptions for each hour of sleep.

The paper reports how AHI changed in each treatment group compared with placebo. If you want exact figures, read the results section directly, since those numbers belong to the study and shouldn't be recalled from memory. Participants were chosen using specific criteria for body weight and AHI, so their experience may not mirror yours.

The study didn't present tirzepatide as a cure. Sleep apnea still needs monitoring, and a lower AHI in a trial doesn't guarantee the same change for every person.

In the United States, the FDA has approved tirzepatide, sold as Zepbound, for moderate-to-severe obstructive sleep apnea in adults with obesity. That indication belongs to Zepbound, not Mounjaro, so check the current prescribing information for the exact wording before assuming how it applies to you.

Snoring, insomnia, and sleep apnea are not the same problem

a hospital room with a bed and a desk

Someone with insomnia lies awake, watches the clock, and struggles to drift off. Someone with sleep apnea may spend seven or eight hours in bed and still wake up feeling like they never rested. Morning headaches, dry mouth, and daytime sleepiness are common clues. Our earlier sleep piece on MounjaBlog covers insomnia in more detail, which can help you sort out which problem fits your experience.

Snoring alone doesn't confirm sleep apnea. Plenty of people snore without any breathing pauses. Loud snoring combined with witnessed pauses, gasping, or heavy daytime sleepiness deserves a medical evaluation. A screening tool called STOP-BANG asks a short set of questions about snoring, tiredness, blood pressure, and body size to estimate risk. It doesn't diagnose anything, but it gives you a useful starting point for talking with a clinician.

What to track before and during treatment

Good tracking gives your clinician real information instead of memories. If you want more background on keeping these logs, the MounjaBlog archive is a good place to browse. Start with these basics:

A sleep log for two to three weeks before the first dose, noting bedtime, wake time, partner reports of snoring or pauses, and daytime sleepiness on a 0 to 10 scale.

Weight and waist or neck measurements taken at the same time of day each week, ideally in the morning before eating, since neck changes may relate to airway size.

Past sleep study results with their dates, plus medication timing, dose, and any nighttime nausea or reflux, since these can affect sleep quality.

Your clinician might also use the Epworth Sleepiness Scale, a questionnaire scored from 0 to 24, where higher scores mean more daytime sleepiness. Sleep studies come in two main forms. In-lab polysomnography is the most comprehensive, while home sleep apnea testing is a simpler option that some people qualify for. Ask which one fits your situation.

Questions to bring to your doctor or sleep specialist

Ask whether a sleep study should happen before you start or continue treatment, and whether a repeat study is planned. Ask how tirzepatide fits into your plan if you already use CPAP or another breathing treatment. CPAP, a machine that keeps the airway open with steady air pressure, is the most common treatment for sleep apnea.

Never stop using CPAP on your own. Even if your symptoms improve, changes to breathing therapy should happen only with medical guidance. Bring your sleep log to the appointment so the conversation starts with real data.

Side effects that can interfere with sleep

Nausea, reduced appetite, constipation, and reflux are among the more common gastrointestinal effects listed in the Mounjaro prescribing information. Any of them can make nights harder. If nausea peaks overnight, ask your prescriber whether changing the timing of your weekly dose could help.

Eating and drinking less can also lead to dehydration. The label warns that gastrointestinal fluid losses can cause dehydration and, in some cases, acute kidney injury. Dehydration may show up as dry mouth, headaches, or restless sleep, so report persistent symptoms promptly.

When your dose goes up, symptoms can shift for a while. Reporting changes early lets your clinician adjust the plan instead of guessing. Other factors can also worsen airway collapse, including sleeping on your back, drinking alcohol close to bedtime, and taking sedating medications. Side sleeping often helps snoring. As we've covered on MounjaBlog, always check with your doctor before changing any sleep aid, including over-the-counter products.

Setting realistic expectations

Some people notice less snoring, fewer headaches, or better energy. Others notice little change. Sleep apnea needs ongoing monitoring whether or not your weight changes, and your doctor may want repeat testing to see how things are going.

This article is educational and doesn't replace personal medical advice. Treatment decisions belong to you and your clinician. If you have questions about symptoms, especially loud snoring with pauses or gasping, talk with a professional soon.

FAQ

Does Mounjaro cure sleep apnea?

No. Research on tirzepatide shows it can reduce breathing events in some adults with obesity and sleep apnea, but the study didn't present it as a cure. Your clinician can explain what to expect in your case.

Can I stop CPAP if I start tirzepatide?

Don't stop CPAP without talking to your doctor or sleep specialist. Any change to breathing treatment should follow a medical evaluation.

Do I need a sleep study before starting treatment?

Ask your clinician. A sleep study can confirm whether you have sleep apnea and how severe it is, giving you a baseline for later comparisons.

Why am I still snoring on Mounjaro?

Snoring can persist for many reasons, including alcohol, sleep position, nasal congestion, or changes that haven't happened yet. Track your symptoms and share the log with your doctor.

Sources